You’re lying awake at 2am, unable to sleep despite exhaustion. You mention this to your GP. They prescribe a sleep medication. Problem solved — except it’s not, really.

Sleep medications work in the short term. They help you fall asleep faster or stay asleep longer. But they don’t fix the underlying causes of insomnia, and they come with side effects and dependency risks.

Cognitive behavioral therapy for insomnia (CBT-I) addresses the root causes — the thoughts, behaviors, and environmental factors perpetuating poor sleep. It’s more effective long-term than medication. The evidence is clear on this.

Yet medication remains the more common treatment. The reasons are practical, not scientific.

The Evidence for CBT-I

Multiple meta-analyses and systematic reviews have found CBT-I to be at least as effective as sleep medications for treating chronic insomnia, and more effective over time once treatment ends.

A landmark 2016 study in JAMA compared CBT-I to medication (zolpidem) and found both effective initially. But at follow-up months later, CBT-I group maintained improvements while the medication group’s insomnia returned when they stopped taking the drug.

This pattern repeats across studies. CBT-I produces durable improvements because it changes the behaviors and thought patterns driving insomnia. Medication masks symptoms without addressing causes.

The American College of Physicians updated clinical guidelines to recommend CBT-I as first-line treatment for chronic insomnia, with medication reserved for situations where CBT-I isn’t available or hasn’t worked.

What CBT-I Actually Involves

CBT-I isn’t a passive treatment. It requires active participation and behavior change over several weeks. Typical programs involve 4-8 sessions with a trained therapist, either in person or via digital platforms.

Components include:

Sleep restriction. Limiting time in bed to match actual sleep time. This builds sleep pressure and consolidates sleep. Initially difficult but effective.

Stimulus control. Associating bed with sleep rather than wakefulness. Getting out of bed when unable to sleep. Only using bed for sleep and sex, not reading, screens, or worrying.

Cognitive therapy. Identifying and challenging unhelpful thoughts about sleep. Reducing anxiety around sleep that perpetuates insomnia.

Sleep hygiene. Optimizing sleep environment and pre-sleep routine. This alone rarely fixes chronic insomnia but supports other interventions.

Relaxation techniques. Methods for reducing physiological arousal that interferes with sleep.

This is structured, skills-based therapy. It takes effort and commitment. But the skills persist after treatment ends, which is why effects last.

Why Medication Gets Prescribed Instead

If CBT-I is more effective long-term, why does medication remain more common?

Accessibility. GPs can prescribe medication in a 10-minute appointment. CBT-I requires referral to a specialized therapist or program, with associated wait times and costs.

Patient preference. Many patients want a quick fix. Taking a pill is easier than weeks of behavior change. When GPs offer both options, patients often choose medication.

Immediate effect. Medication works the first night. CBT-I takes several weeks to show benefits. For someone desperate for sleep, waiting weeks is unappealing.

Insurance coverage. Medication is typically covered. CBT-I might not be, or might require higher out-of-pocket costs than patients can afford.

GP training. Most GPs aren’t trained to deliver CBT-I. Referring to specialists is an option but adds complexity.

Medication Risks

Sleep medications aren’t benign. Risks include:

Tolerance. Over time, the same dose becomes less effective. Higher doses carry more side effects and dependency risk.

Dependency. Physical and psychological dependence can develop, making it difficult to stop medication even when patients want to.

Next-day effects. Grogginess, impaired cognition, increased fall risk in older adults.

Rebound insomnia. When medication is stopped, insomnia often returns worse than before. This reinforces continued use.

Interaction with other medications. Sleep meds can interact with other drugs, limiting their use in patients with complex medication regimens.

These risks are manageable with appropriate prescribing — lowest effective dose, short-term use, monitoring for problems. But in practice, many patients end up on long-term sleep medications without a plan for discontinuation.

Digital CBT-I

Accessibility has improved with digital CBT-I programs. Apps and online platforms deliver CBT-I components via interactive modules, sleep diaries, and automated coaching.

Research shows digital CBT-I is effective, though generally slightly less so than therapist-delivered programs. But it’s more accessible and less expensive, making it viable for more people.

Programs like Sleepio have been clinically validated and are available in Australia. Some are covered by health insurance. Others charge subscription fees.

Digital CBT-I isn’t for everyone — some people need the accountability and personalization of therapist-delivered care. But it’s a significant improvement over no CBT-I access at all.

Combining Approaches

CBT-I and medication aren’t mutually exclusive. Some patients benefit from short-term medication to break a severe insomnia cycle while simultaneously engaging in CBT-I to address underlying causes.

The goal is eventually discontinuing medication while maintaining improvements through CBT-I skills. This combined approach can work well when both are available and the plan is clearly communicated.

The System Barriers

For CBT-I to become truly first-line treatment, several things need to change:

More trained therapists. Sleep psychologists who can deliver CBT-I are in short supply. Training more and making it a viable career pathway would expand capacity.

Better GP education. GPs need training on when to recommend CBT-I, how to discuss it with patients, and where to refer.

Insurance coverage. CBT-I should be covered as readily as medication. When cost is a barrier, the more expensive long-term option (ongoing medication) gets chosen over the cost-effective option (time-limited CBT-I).

Digital platform integration. GPs should be able to directly prescribe access to validated digital CBT-I platforms as easily as prescribing medication.

For healthcare organizations trying to improve insomnia care pathways, working with specialists like Team400 on digital health integration and workflow optimization could help make CBT-I more accessible within existing systems. Technology alone doesn’t solve the problem, but it’s part of the solution.

The Patient Perspective

If you have chronic insomnia, asking your GP about CBT-I is worth doing even if they haven’t mentioned it. Digital programs are available if in-person therapy isn’t accessible.

Medication can be appropriate for short-term use — during a crisis, after a traumatic event, when sleep deprivation is severe and immediate relief is needed. But for chronic insomnia lasting months or years, CBT-I should be part of the plan.

It’s harder than taking a pill. It requires work. But it actually fixes the problem rather than temporarily masking it. That’s worth the effort for most people.

The Bottom Line

CBT-I is more effective than medication for chronic insomnia when measured over time. The evidence is robust. Yet medication remains more commonly prescribed because of accessibility, patient preference, and system constraints.

This gap between evidence and practice is slowly closing. Digital CBT-I is making treatment more accessible. Clinical guidelines are clearer. Awareness is growing.

If you’re taking sleep medication long-term, it’s worth discussing CBT-I with your physician. You might still need medication, but addressing underlying causes gives you the best chance of eventually sleeping well without it. That’s the goal worth pursuing.